CDC5L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.483400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.662000E-01
Normal-vs-Stage2
8.356800E-01
Normal-vs-Stage3
8.775500E-02
Normal-vs-Stage4
2.457200E-01
Stage1-vs-Stage2
9.239600E-01
Stage1-vs-Stage3
2.280800E-01
Stage1-vs-Stage4
1.258020E-01
Stage2-vs-Stage3
1.923350E-01
Stage2-vs-Stage4
5.574400E-02
Stage3-vs-Stage4
3.278100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.542600E-01
Normal-vs-AfricanAmerican
8.617600E-01
Normal-vs-Asian
3.971600E-01
Caucasian-vs-AfricanAmerican
5.621000E-01
Caucasian-vs-Asian
1.750440E-01
AfricanAmerican-vs-Asian
2.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.807600E-01
Normal-vs-Female
8.084800E-01
Male-vs-Female
8.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.579210E-01
Normal-vs-Age(41-60Yrs)
7.922000E-01
Normal-vs-Age(61-80Yrs)
6.733000E-01
Normal-vs-Age(81-100Yrs)
8.165600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.013200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.671400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.922200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.622150E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.465200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.008200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.546800E-01
Normal-vs-Daily Drinker
2.366800E-01
Normal-vs-Weekly Drinker
7.779200E-01
Normal-vs-Occasional Drinker
7.218800E-01
Normal-vs-Social Drinker
8.975600E-01
Non Drinker-vs-Daily Drinker
2.879000E-01
Non Drinker-vs-Weekly Drinker
4.894400E-01
Non Drinker-vs-Occasional Drinker
3.872100E-02
Non Drinker-vs-Social Drinker
3.034200E-01
Daily Drinker-vs-Weekly Drinker
1.539190E-01
Daily Drinker-vs-Occasional Drinker
9.795500E-03
Daily Drinker-vs-Social Drinker
8.240300E-02
Weekly Drinker-vs-Occasional Drinker
2.896600E-01
Weekly Drinker-vs-Social Drinker
8.023800E-01
Occasional Drinker-vs-Social Drinker
3.966200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.420000E-01
Normal-vs-Grade 2
6.807600E-01
Normal-vs-Grade 3
6.750000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.582820E-01
Grade 1-vs-Grade 3
1.795400E-01
Grade 1-vs-Grade 4
4.420000E-01
Grade 2-vs-Grade 3
9.003800E-01
Grade 2-vs-Grade 4
6.807600E-01
Grade 3-vs-Grade 4
6.750000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.997200E-01
Normal-vs-NonDiabetic
7.328600E-01
Diabetic-vs-NonDiabetic
5.255600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.220000E-01
Normal-vs-NoPancreatitis
7.841600E-01
Pancreatitis-vs-NoPancreatitis
3.723900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.236800E-01
Normal-vs-N1
8.734000E-01
N0-vs-N1
8.496800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.052600E-01
Normal-vs-TP53-NonMutant
8.989400E-01
TP53-Mutant-vs-TP53-NonMutant
6.634800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
